GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $225,000 | -44.3% | 2,310 | -29.8% | 0.00% | -50.0% |
Q2 2020 | $404,000 | -12.2% | 3,292 | -37.3% | 0.01% | -11.1% |
Q1 2020 | $460,000 | -20.0% | 5,250 | -4.5% | 0.01% | 0.0% |
Q4 2019 | $575,000 | +24.2% | 5,496 | +36.6% | 0.01% | +12.5% |
Q3 2019 | $463,000 | -25.7% | 4,024 | +11.4% | 0.01% | -33.3% |
Q2 2019 | $623,000 | +5.8% | 3,611 | +3.3% | 0.01% | +20.0% |
Q1 2019 | $589,000 | +89.4% | 3,494 | +94.0% | 0.01% | +66.7% |
Q3 2018 | $311,000 | +3010.0% | 1,801 | +1701.0% | 0.01% | – |
Q2 2017 | $10,000 | -16.7% | 100 | 0.0% | 0.00% | – |
Q1 2017 | $12,000 | +9.1% | 100 | 0.0% | 0.00% | – |
Q4 2016 | $11,000 | -15.4% | 100 | 0.0% | 0.00% | – |
Q3 2016 | $13,000 | 0.0% | 100 | -32.4% | 0.00% | – |
Q2 2016 | $13,000 | +85.7% | 148 | +48.0% | 0.00% | – |
Q1 2016 | $7,000 | +16.7% | 100 | 0.0% | 0.00% | – |
Q4 2015 | $6,000 | -33.3% | 100 | 0.0% | 0.00% | – |
Q3 2015 | $9,000 | -25.0% | 100 | 0.0% | 0.00% | – |
Q2 2015 | $12,000 | +33.3% | 100 | 0.0% | 0.00% | – |
Q1 2015 | $9,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |